Cargando…
A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants
BACKGROUND: Medication-related osteonecrosis of the jaw (MRONJ) is characterized by the development of bone necrosis in the jaws of patients receiving antiresorptive and/or antiangiogenic medications. No scientific reports have been published yet on bevacizumab-related osteonecrosis of the jaw (BeRO...
Autores principales: | Maluf, Gustavo, Caldas, Rogério Jardim, Fregnani, Eduardo Rodrigues, da Silva Santos, Paulo Sérgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768921/ https://www.ncbi.nlm.nih.gov/pubmed/31571065 http://dx.doi.org/10.1186/s40729-019-0188-0 |
Ejemplares similares
-
Leukocyte- and platelet-rich fibrin as an adjuvant to the surgical approach for osteoradionecrosis: a case report
por: Maluf, Gustavo, et al.
Publicado: (2020) -
Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
por: Maciel, Aloizio Premoli, et al.
Publicado: (2020) -
Bisphosphonate-related osteonecrosis of the jaw and dental implants
por: Qamheya, Ala Hassan A., et al.
Publicado: (2016) -
Tomographic study of Jaw bone changes in patients with bisphosphonate-related osteonecrosis
por: Simpione, Guilherme, et al.
Publicado: (2020) -
Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
por: Caminha, Raquel D’Aquino Garcia, et al.
Publicado: (2019)